
    
      This study is double blind (neither you nor the physician will know when you are receiving
      placebo, which is an inactive compound such as a sugar pill, or active study drugs nebivolol
      or hydrochlorothiazide).

      All participants will also receive lisinopril, an angiotensin converting enzyme, or losartan,
      an angiotensin receptor blocker. All medications are approved and marketed for the treatment
      of hypertension.This study is being conducted in about 500 patients at approximately 80
      research centers in the United States.

      The study consists of approximately 9 study visits over a period of 5 months. During these
      visits, patients will undergo routine health exams and some special laboratory tests such as
      an oral glucose tolerance test.
    
  